- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0015578

Smithways Pharma Private Limited
About Smithways Pharma Private Limited
Data last updated:
Smithways Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 11 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2019PTC354952.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sunil Dutt and Navrati Rajpurohit.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 2/151 Ground Floor Sector – 11 Rohini, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.49 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹10.2 Lakh (net margin 4.1%) and EBITDA of ₹14.56 Lakh (EBITDA margin 5.8%).
Smithways Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0015578).
Company details
Recognitions & Rankings of Smithways Pharma
Contact details
Smithways Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressF – 2/151 Ground Floor Sector – 11 Rohini, New Delhi, Delhi, India – 110085
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Smithways Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Smithways Pharma Private Limited
FY 2025 filings availableSmithways Pharma Private Limited reported revenue of ₹2.49 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 7% in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Smithways Pharma Private Limited, buy the company report.
Board of directors of Smithways Pharma Private Limited
Smithways Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Dutt Also directs: Smithways Health Care Private Limited | Director | 29 Sep 2019 | 7 Years 1 Months | Current |
| Navrati Rajpurohit Also directs: Smithways Health Care Private Limited, Winx Medihaat Innovations Private Limited, Way2door Logistics Private Limited and 1 more | Additional Director | 12 Jan 2026 | 0 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Smithways Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Smithways Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Smithways Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Smithways Pharma Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Navrati Rajpurohit was appointed as Additional Director on 12 Jan 2026.
Frequently asked questions
Smithways Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 11 September 2019 (7+ years old) and is registered under CIN U24230DL2019PTC354952.
Smithways Pharma has 2 current directors:
- Sunil Dutt - Director
- Navrati Rajpurohit - Additional Director
The latest financial statements of Smithways Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Smithways Pharma is U24230DL2019PTC354952. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Smithways Pharma was incorporated on 11 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Navrati Rajpurohit was appointed as Additional Director on 12 Jan 2026. Sajjan Rajpurohit ceased to be Director on 06 Nov 2020. Sunil Dutt was appointed as Director on 29 Sep 2019. Smithways Pharma has 4 board changes on record in total.
Yes, Smithways Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0015578).
The registered office of Smithways Pharma is at F – 2151 Ground Floor Sector – 11 Rohini, New Delhi, Delhi, India – 110085.
Smithways Pharma operates in the chemicals industry, in the manufacturing segment.
Smithways Pharma can be reached at its registered office: F – 2151 Ground Floor Sector – 11 Rohini, New Delhi, Delhi, India – 110085.

